Kohjin Bio Co Ltd (177A)

Currency in JPY
1,784.00
+16.00(+0.90%)
Closed·
177A Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
Earnings results expected in 8 days
177A is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,750.001,786.00
52 wk Range
1,400.002,048.00
Key Statistics
Bid/Ask
1,770.00 / 1,785.00
Prev. Close
1,784
Open
1,760
Day's Range
1,750-1,786
52 wk Range
1,400-2,048
Volume
4.8K
Average Volume (3m)
5.66K
1-Year Change
33.68%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
177A Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Kohjin Bio Co Ltd Company Profile

Kohjin Bio Co., Ltd. manufactures and sells animal blood, sera, tissue culture media, agar media for microorganism tests, in-vitro diagnostic agents, and cosmetics. The company offers tissue culture mediums for virus and recombinant protein production, hybridoma, human lymphocyte culture, and insect cell lines; gas permeable cell culture bags and other materials; cryopreservation agent of cells; medium supplements; normal human cells; normal human cell mediums; ES cell mediums; in-vitro fertilization and early embryo culture kits; and other culture and related products, such as supplements, cell separation solutions, physiological salt solutions, and research reagents. The company also offers clinical microbiology culture mediums for gram positive cocci, gram negative bacteria, and susceptibility testing; general differential, anaerobic growth, and fungal mediums; tube mediums for confirmation and expansion; microbiology culture mediums for food, such as mediums for sterilization test, E. coli and coliform bacteria, staphylococcus spp., bacillus cereus, and vibrio parahaemolyticus; culture mediums for determining total viable cell count; and campylobacter and fungal mediums. In addition, the company offers normal human blood, serum, and plasma; pathological human serum; preserved animal blood; defibrinated and hemolyzed animal blood; animal serum and plasma; and other custom-designed products, such as eagle medium. Further, the company engages in the production and sale of laboratory animal, sale of medical equipment, trust of animal immunization and antibody preparation, and import and export of products and raw materials. The company was formerly known as Kohjin Co.,Ltd and changed its name to Kohjin Bio Co., Ltd. in 1989. The company was incorporated in 1981 and is based in Sakado, Japan.

Employees
167
Market
Japan

Compare 177A to Peers and Sector

Metrics to compare
177A
Peers
Sector
Relationship
P/E Ratio
11.4x−5.8x−0.5x
PEG Ratio
0.160.000.00
Price/Book
1.6x4.5x2.6x
Price / LTM Sales
1.7x31.5x3.3x
Upside (Analyst Target)
-61.7%42.8%
Fair Value Upside
Unlock13.9%6.5%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 157.41%
Dividend Yield
1.35%
Industry Median 2.48%
Annualised payout
24.00
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 14, 2025
EPS / Forecast
54.62 / --
Revenue / Forecast
1.28B / --
EPS Revisions
Last 90 days

177A Income Statement

FAQ

What Stock Exchange Does Kohjin Bio Trade On?

Kohjin Bio is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for Kohjin Bio?

The stock symbol for Kohjin Bio is "177A."

What Is the Kohjin Bio Market Cap?

As of today, Kohjin Bio market cap is 9.12B.

What Is Kohjin Bio's Earnings Per Share (TTM)?

The Kohjin Bio EPS (TTM) is 157.41.

When Is the Next Kohjin Bio Earnings Date?

Kohjin Bio will release its next earnings report on 13 Aug 2025.

From a Technical Analysis Perspective, Is 177A a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Kohjin Bio Stock Split?

Kohjin Bio has split 0 times.

How Many Employees Does Kohjin Bio Have?

Kohjin Bio has 167 employees.

What is the current trading status of Kohjin Bio (177A)?

As of 06 Aug 2025, Kohjin Bio (177A) is trading at a price of 1,784.00, with a previous close of 1,784.00. The stock has fluctuated within a day range of 1,750.00 to 1,786.00, while its 52-week range spans from 1,400.00 to 2,048.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.